The Procter & Gamble Company (NYSE:PG) Shares Purchased by Journey Strategic Wealth LLC

Journey Strategic Wealth LLC raised its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 1.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 7,249 shares of the company’s stock after purchasing an additional 114 shares during the period. Journey Strategic Wealth LLC’s holdings in Procter & Gamble were worth $1,062,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Demars Financial Group LLC boosted its position in shares of Procter & Gamble by 4.4% in the fourth quarter. Demars Financial Group LLC now owns 1,497 shares of the company’s stock valued at $219,000 after acquiring an additional 63 shares during the period. Emerald Advisors LLC lifted its position in Procter & Gamble by 1.8% during the fourth quarter. Emerald Advisors LLC now owns 3,775 shares of the company’s stock worth $553,000 after purchasing an additional 65 shares during the period. O Brien Wealth Partners LLC lifted its position in Procter & Gamble by 3.3% during the fourth quarter. O Brien Wealth Partners LLC now owns 2,062 shares of the company’s stock worth $302,000 after purchasing an additional 65 shares during the period. Mechanics Financial Corp lifted its position in Procter & Gamble by 0.4% during the fourth quarter. Mechanics Financial Corp now owns 16,184 shares of the company’s stock worth $2,372,000 after purchasing an additional 65 shares during the period. Finally, LWM Advisory Services LLC lifted its position in Procter & Gamble by 2.1% during the fourth quarter. LWM Advisory Services LLC now owns 3,143 shares of the company’s stock worth $461,000 after purchasing an additional 66 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock traded down $0.24 during trading hours on Monday, hitting $167.40. 3,804,626 shares of the company’s stock traded hands, compared to its average volume of 6,733,932. The Procter & Gamble Company has a 12-month low of $141.45 and a 12-month high of $168.34. The stock has a market capitalization of $395.09 billion, a price-to-earnings ratio of 27.35, a PEG ratio of 3.40 and a beta of 0.43. The company has a fifty day simple moving average of $161.31 and a 200-day simple moving average of $155.46. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The company had revenue of $20.20 billion during the quarter, compared to analyst estimates of $20.43 billion. During the same quarter last year, the firm posted $1.37 EPS. The firm’s revenue for the quarter was up .6% on a year-over-year basis. Equities research analysts anticipate that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were given a dividend of $1.0065 per share. The ex-dividend date was Thursday, April 18th. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 annualized dividend and a dividend yield of 2.41%. Procter & Gamble’s dividend payout ratio is currently 65.85%.

Analyst Ratings Changes

Several brokerages have commented on PG. Barclays boosted their target price on Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 23rd. Jefferies Financial Group boosted their target price on Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a research note on Monday, April 22nd. UBS Group upped their price objective on Procter & Gamble from $172.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, January 24th. Royal Bank of Canada upped their price objective on Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 24th. Finally, The Goldman Sachs Group initiated coverage on Procter & Gamble in a research note on Friday, March 1st. They issued a “neutral” rating and a $168.00 price objective for the company. Seven investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $169.76.

View Our Latest Analysis on PG

Insider Activity

In other news, insider Balaji Purushothaman sold 28,369 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the completion of the transaction, the insider now owns 11,507 shares of the company’s stock, valued at $1,858,265.43. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the completion of the sale, the chief executive officer now owns 4,859 shares of the company’s stock, valued at $768,256.49. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Balaji Purushothaman sold 28,369 shares of the business’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total value of $4,581,309.81. Following the completion of the sale, the insider now owns 11,507 shares of the company’s stock, valued at approximately $1,858,265.43. The disclosure for this sale can be found here. Insiders have sold a total of 149,261 shares of company stock worth $24,375,791 over the last ninety days. Company insiders own 0.17% of the company’s stock.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.